Janet Liang
Known title: President, Oscar InsuranceCIK: 0001888381
Associated companies
Transaction History
| OSCR | ▼ Sell | Open Market | 10,360 | $326K | 9/3/2026 | View on chart |
| OSCR | ▼ Sell | Open Market | 8,940 | $194K | 6/2/2026 | View on chart |
| OSCR | ▼ Sell | Open Market | 3,535 | $79K | 6/2/2026 | View on chart |
| OSCR | ▼ Sell | Open Market | 7,453 | $100K | 3/2/2026 | View on chart |
| OSCR | ▲ Buy | Grant | 106,458 | $0 | 3/2/2026 | View on chart |
| OSCR | ▼ Sell | Open Market | 7,338 | $122K | 12/2/2025 | View on chart |
| OSCR | ▼ Sell | Tax Withholding | 7,303 | $122K | 9/2/2025 | View on chart |
| OSCR | ▼ Sell | Tax Withholding | 7,196 | $99K | 6/2/2025 | View on chart |
| OSCR | ▲ Buy | Grant | 96,962 | $0 | 3/5/2025 | View on chart |
| OSCR | ▲ Buy | Grant | 97,402 | $0 | 2/24/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Oscar Health Analyst Target Rises to $34.19
Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.
Oscar Health Analyst Target Rises to $34.19. Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.